0001127602-23-026390.txt : 20231031 0001127602-23-026390.hdr.sgml : 20231031 20231031110820 ACCESSION NUMBER: 0001127602-23-026390 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231030 FILED AS OF DATE: 20231031 DATE AS OF CHANGE: 20231031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oosthuizen Johannes Jacobus CENTRAL INDEX KEY: 0001916310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 231362799 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL RD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-10-30 0000310158 Merck & Co., Inc. MRK 0001916310 Oosthuizen Johannes Jacobus MERCK & CO., INC. 126 EAST LINCOLN AVENUE RAHWAY NJ 07065 1 President, U.S. Market 0 Common Stock 2023-10-30 4 M 0 915 102.82 A 20722.657 D Common Stock 2023-10-30 4 F 0 451 102.82 D 20271.657 D Restricted Stock Unit 2023-10-30 4 M 0 915 0 D 2021-10-30 2023-10-30 Common Stock 915 0 D Holdings include shares acquired in dividend reinvestment transactions. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023. /s/ Kelly E. W. Grez, as attorney-in-fact for Johannes Oosthuizen 2023-10-31